Newsroom
Sorted by: Latest
-
Pliant Secures FCA Authorisation as an Electronic Money Institution to Accelerate Expansion
LONDON--(BUSINESS WIRE)--Pliant announces that it has received full authorisation from the Financial Conduct Authority as an Electronic Money Institution...
-
Alentis and PinotBio Announce Collaboration to Develop Next-Generation ADCs Targeting claudin-1
BASEL, Switzerland & SUWON, South Korea--(BUSINESS WIRE)--Under the agreement, Alentis and PinotBio will discover and develop next-generation antibody-drug conjugates targeting claudin-1 for oncology....
-
Deutsche Bank AG UK Regulatory Announcement: FRN Variable Rate Fix
LONDON--(BUSINESS WIRE)-- Commonwealth Bank of Australia Issue of USD 10,000,000.00 Floating Rate Notes due April 2033 Series 6522 Tranche 1 MTN ISSUE NAME. Our Ref. MP5632 ISIN Code. XS2614239015 TOTAL INTEREST AMT. CURRENCY CODE. USD DAY BASIS. Actual/360 (A004) NUM OF DAYS. 92 INTEREST RATE. 4.7409 PCT VALUE DATE. 20/10/2026 INTEREST PERIOD. 20/07/2026 TO 20/10/2026 USD 121,156.33 POOL FACTOR. N/A...
-
UNPACK ’27: EXPEDIA AND HOTELS.COM REVEAL THE TRAVEL TRENDS INSPIRING THE WORLD IN 2027
LONDON--(BUSINESS WIRE)--Expedia Group today unveiled Unpack ’27: The Trends in Travel™, the annual report exploring the destinations, experiences, and behaviours expected to shape travel in 2027. Drawing on first-party insight from Expedia, Hotels.com, and Vrbo, as well as global traveller research and social listening, Unpack ’27 reveals the new places drawing travellers in 2027 and some surprising things they're doing when they get there. “Travel is about creating memories, and Unpack ’27 un...
-
AL-S Pharma Appoints Harry Welten as Chief Executive Officer
ZURICH, Switzerland--(BUSINESS WIRE)--AL-S Pharma AG (“AL-S Pharma” or “the Company”), a clinical-stage biotechnology company discovering and developing human antibodies that target misfolded proteins implicated in amyotrophic lateral sclerosis (ALS), today announced the appointment of Harry Welten as chief executive officer (CEO). Mr. Welten succeeds Michael Salzmann, Ph.D. The Company recently reported positive topline results from a Phase 2 study of its lead program AP-101, a human monoclonal...
-
Pershing Square Holdings, Ltd. UK Regulatory Announcement: Transaction in Own Shares
LONDON--(BUSINESS WIRE)-- Pershing Square Holdings, Ltd. Announces Transactions in Own Shares - 13 October 2026 Pershing Square Holdings, Ltd. (LN:PSH) (LN:PSHD) (“PSH”) today announced that it has purchased, through PSH’s agent, Jefferies International Limited (“Jefferies”), the following number of PSH’s Public Shares of no par value (ISIN Code: GG00BPFJTF46) (the "Shares"): Total Buyback Ticker/s: PSH (LSE); PSHD (LSE) Date of Purchase: 13 October 2026 Number of Public Shares Purchased: 30...
-
Kyocera Document Solutions Sponsors Retrospective Exhibition Celebrating ANREALAGE's 25th Participation in Paris Fashion Week
OSAKA, Japan--(BUSINESS WIRE)--Kyocera Document Solutions Inc. (President: Takashi Nagai) is pleased to announce that it sponsored a retrospective exhibition commemorating the 25th participation of the fashion brand ANREALAGE in Paris Fashion Week. The exhibition was held in Paris, France, from October 2 to October 5, 2026. The collaboration between Kyocera Document Solutions and ANREALAGE began in 2024. Since then, printing technology using Kyocera's FOREARTH sustainable inkjet textile printer...
-
Advanced Bionics erhält TÜV-Zulassung für die Integro™ CI Cochlea-Implantat-Plattform
VALENCIA, Kalifornien--(BUSINESS WIRE)--Advanced Bionics (AB), eine Marke von Sonova, gab heute bekannt, dass Integro CI nach der CE-Kennzeichnung die TÜV-Zulassung erhalten hat. Integro CI ist die Cochlea-Implantat-Plattform der nächsten Generation. Integro CI kombiniert die Cochlea-Implantat-Technologie von Advanced Bionics mit Innovationen von Phonak. Die neuen Soundprozessoren bieten die SoundFinder™-Technologie zur Schalllokalisierung, KI-gestützte SmartSpeech-Technologie sowie eine erweit...
-
CTP Launches 200,000 sqm CTPark Castel San Giovanni, Its First Branded Logistics Park in Italy
AMSTERDAM--(BUSINESS WIRE)--Regulatory News: CTP, Europe’s largest listed owner, developer and manager of logistics and industrial real estate by gross lettable area (GLA), has launched CTPark Castel San Giovanni, its first branded logistics park in Italy, with a total planned size of nearly 200,000 sqm, following the completion of a 52,000 sqm build-to-suit facility for a leading international logistics operator. This marks the launch of the first CTP branded park in Italy following its entry...
-
Galderma Signs Agreement to Acquire ZO Skin Health, Strengthening Its Physician-Dispensed Skincare Offering
ZUG, Switzerland & IRVINE, Calif.--(BUSINESS WIRE)--Galderma (SIX: GALD) today announced that it has signed an agreement to acquire ZO® Skin Health, a leading physician-dispensed skincare brand built on clinical science and protocol-based daily care, from its shareholders, including funds managed by Blackstone Tactical Opportunities (“Blackstone”) and the Obagi family. Founded by dermatologist Dr. Zein Obagi and headquartered in Irvine, California, ZO Skin Health has been a reference name in cl...